Artiva's IPO raises $167M to fund company's autoimmune and cancer cell therapies
Cell therapy startup Artiva Biotherapeutics will go public on Friday morning in the 11th biotech IPO this year. Its Wall Street debut adds to the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
